Codexis (CDXS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.24, -8.82% vs the prior close of $1.36.
- Volume 980.07K shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CDXS slides 8.8% to $1.24, a 6-month low. Closed at $1.24, -8.82% vs the prior close of $1.36. Day range $1.22–$1.36, opened at $1.36.
CDXS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CDXS slides 8.8% to $1.24, a 6-month low
- Closed at $1.24, -8.82% vs the prior close of $1.36. Day range $1.22–$1.36, opened at $1.36.
- Volume was 980.07K shares, 1.0x its 50-day average of 951.29K.
- Price is -14.9% vs its 50-day average ($1.46) and -32.5% vs its 200-day average ($1.84).
- 52-week range $0.96–$2.98; today's close sits at 14% of that range, 58.4% below the 52-week high.
Oct 15, 2026 — CDXS jumps 5.4% to $1.36
- Closed at $1.36, +5.43% vs the prior close of $1.29. Day range $1.26–$1.36, opened at $1.29.
- Volume was 681.10K shares, 0.7x its 50-day average of 953.29K.
- Price is -7.0% vs its 50-day average ($1.46) and -26.1% vs its 200-day average ($1.84).
- 52-week range $0.96–$2.98; today's close sits at 20% of that range, 54.4% below the 52-week high.
Oct 14, 2026 — CDXS dips 2.3% to $1.29, a 6-month low, 3 down days in a row
- Closed at $1.29, -2.27% vs the prior close of $1.32. Day range $1.27–$1.34, opened at $1.30.
- Volume was 931.60K shares, 1.0x its 50-day average of 948.41K.
- Price is -11.8% vs its 50-day average ($1.46) and -29.9% vs its 200-day average ($1.84).
- 52-week range $0.96–$2.98; today's close sits at 16% of that range, 56.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — CDXS slides 6.4% to $1.32
- Closed at $1.32, -6.38% vs the prior close of $1.41. Day range $1.31–$1.41, opened at $1.39.
- Volume was 820.30K shares, 0.9x its 50-day average of 948.13K.
- Price is -10.0% vs its 50-day average ($1.47) and -28.4% vs its 200-day average ($1.84).
- 52-week range $0.96–$2.98; today's close sits at 18% of that range, 55.7% below the 52-week high.
Oct 12, 2026 — CDXS ends flat (+0.0%) to $1.41
- Closed at $1.41, +0.00% vs the prior close of $1.41. Day range $1.32–$1.43, opened at $1.40.
- Volume was 1.10M shares, 1.2x its 50-day average of 948.80K.
- Price is -4.0% vs its 50-day average ($1.47) and -23.6% vs its 200-day average ($1.84).
- 52-week range $0.96–$2.98; today's close sits at 22% of that range, 52.7% below the 52-week high.
Oct 9, 2026 — CDXS jumps 3.7% to $1.41
- Closed at $1.41, +3.68% vs the prior close of $1.36. Day range $1.34–$1.41, opened at $1.36.
- Volume was 555.40K shares, 0.6x its 50-day average of 952.42K — lighter than usual.
- Price is -4.0% vs its 50-day average ($1.47) and -23.6% vs its 200-day average ($1.85).
- 52-week range $0.96–$2.98; today's close sits at 22% of that range, 52.7% below the 52-week high.
Oct 8, 2026 — CDXS slides 3.5% to $1.36
- Closed at $1.36, -3.55% vs the prior close of $1.41. Day range $1.35–$1.40, opened at $1.39.
- Volume was 887.20K shares, 0.9x its 50-day average of 954.83K.
- Price is -7.5% vs its 50-day average ($1.47) and -26.4% vs its 200-day average ($1.85).
- 52-week range $0.96–$2.98; today's close sits at 20% of that range, 54.4% below the 52-week high.
Oct 7, 2026 — CDXS jumps 3.7% to $1.41
- Closed at $1.41, +3.68% vs the prior close of $1.36. Day range $1.33–$1.45, opened at $1.33.
- Volume was 958.20K shares, 1.0x its 50-day average of 965.95K.
- Price is -4.2% vs its 50-day average ($1.47) and -23.7% vs its 200-day average ($1.85).
- 52-week range $0.96–$2.98; today's close sits at 22% of that range, 52.7% below the 52-week high.
Oct 6, 2026 — CDXS dips 2.2% to $1.36
- Closed at $1.36, -2.16% vs the prior close of $1.39. Day range $1.36–$1.45, opened at $1.40.
- Volume was 597.90K shares, 0.6x its 50-day average of 1.03M — lighter than usual.
- Price is -7.7% vs its 50-day average ($1.47) and -26.5% vs its 200-day average ($1.85).
- 52-week range $0.96–$2.98; today's close sits at 20% of that range, 54.4% below the 52-week high.
Oct 5, 2026 — CDXS rises 2.2% to $1.39
- Closed at $1.39, +2.21% vs the prior close of $1.36. Day range $1.34–$1.41, opened at $1.38.
- Volume was 893.20K shares, 0.7x its 50-day average of 1.22M.
- Price is -5.9% vs its 50-day average ($1.48) and -24.9% vs its 200-day average ($1.85).
- 52-week range $0.96–$2.98; today's close sits at 21% of that range, 53.4% below the 52-week high.
Oct 2, 2026 — CDXS ends flat (+0.0%) to $1.36
- Closed at $1.36, +0.00% vs the prior close of $1.36. Day range $1.35–$1.41, opened at $1.39.
- Volume was 551.90K shares, 0.4x its 50-day average of 1.23M — lighter than usual.
- Price is -8.1% vs its 50-day average ($1.48) and -26.6% vs its 200-day average ($1.85).
- 52-week range $0.96–$2.98; today's close sits at 20% of that range, 54.4% below the 52-week high.
CDXS latest news & SEC filings
Every SEC filing by or about CDXS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Erbez Georgia sold 6,335 shares at $1.36 (≈$8.62K) on Oct 12, 2026; now holds 60,475
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Moore Alison sold 6,335 shares at $1.36 (≈$8.62K) on Oct 12, 2026; now holds 244,171
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 13, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $14.91M (prior year $15.33M) (-2.7% vs Jun 30, 2025)
- Net income: -$12.01M (prior year -$13.27M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.13 (prior year -$0.16) (loss narrowed vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 24, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 23, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 20, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade CDXS
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: Jul 23, 2026, May 7, 2026, Mar 11, 2026. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.72% (largest 8.8%).
- Liquidity: about 773.01K shares (≈$958.53K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.24 vs a range of $0.96–$2.98 (14% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Vre Raymond De sold 2,605 shares on Jun 11, 2026.
- Latest filings: 10-Q Aug 11, 2026; 8-K Aug 11, 2026; 8-K Jul 27, 2026.
- Share count: 109.51M shares outstanding (Aug 6, 2026), +21.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Industrial Organic Chemicals.
CDXS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.36 | 1.36 | 1.22 | 1.24 | 980.07K |
| Oct 15, 2026 | 1.29 | 1.36 | 1.26 | 1.36 | 681.10K |
| Oct 14, 2026 | 1.30 | 1.34 | 1.27 | 1.29 | 931.60K |
| Oct 13, 2026 | 1.39 | 1.41 | 1.31 | 1.32 | 820.30K |
| Oct 12, 2026 | 1.40 | 1.43 | 1.32 | 1.41 | 1.10M |
| Oct 9, 2026 | 1.36 | 1.41 | 1.34 | 1.41 | 555.40K |
| Oct 8, 2026 | 1.39 | 1.40 | 1.35 | 1.36 | 887.20K |
| Oct 7, 2026 | 1.33 | 1.45 | 1.33 | 1.41 | 958.20K |
| Oct 6, 2026 | 1.40 | 1.45 | 1.36 | 1.36 | 597.90K |
| Oct 5, 2026 | 1.38 | 1.41 | 1.34 | 1.39 | 893.20K |
| Oct 2, 2026 | 1.39 | 1.41 | 1.35 | 1.36 | 551.90K |
| Oct 1, 2026 | 1.39 | 1.41 | 1.34 | 1.36 | 752.10K |
| Sep 30, 2026 | 1.36 | 1.41 | 1.35 | 1.39 | 909.80K |
| Sep 29, 2026 | 1.36 | 1.39 | 1.35 | 1.35 | 606.40K |
| Sep 28, 2026 | 1.31 | 1.39 | 1.31 | 1.36 | 698.90K |
| Sep 25, 2026 | 1.38 | 1.40 | 1.32 | 1.32 | 464.30K |
| Sep 24, 2026 | 1.38 | 1.42 | 1.35 | 1.37 | 863.60K |
| Sep 23, 2026 | 1.39 | 1.40 | 1.32 | 1.38 | 627.70K |
| Sep 22, 2026 | 1.39 | 1.43 | 1.38 | 1.39 | 1.04M |
| Sep 21, 2026 | 1.38 | 1.43 | 1.36 | 1.38 | 539.70K |
About Codexis
Codexis (CDXS) is listed on the Nasdaq and classified by the SEC under “Industrial Organic Chemicals”. Its business address is in REDWOOD CITY, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1200375.
CDXS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Cynthia Collins | Director | Jun 18, 2026 |
| Stephen George Dilly | Director | Jun 18, 2026 |
| Vre Raymond De | Director | Jun 18, 2026 |
| Alison Moore | President and CEO | Feb 25, 2026 |
| Esther Martinborough | Director | Jun 18, 2026 |
| H Stewart Parker | Director | Jun 18, 2026 |
| Christos Richards | Director | Jun 18, 2026 |
| Rahul Singhvi | Director | Jun 18, 2026 |
| David V Smith | Director | Jun 18, 2026 |
| Dennis P Wolf | Director | Nov 25, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Georgia Erbez | See Remarks | Feb 25, 2026 |
| Stefan Lutz | Chief Scientific Officer | Feb 25, 2026 |
| Alison Moore | President and CEO | Feb 25, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 11, 2026 | Vre Raymond De | Sale | 2,605 | $2.37 |
| Jun 11, 2026 | Vre Raymond De | Sale | 2,605 | $2.37 |
| Jun 11, 2026 | Vre Raymond De | Sale | 2,605 | $2.37 |
| Jun 11, 2026 | Vre Raymond De | Sale | 2,605 | $2.37 |
| Feb 24, 2026 | Stefan Lutz | Sale | 5,862 | $1.13 |
| Feb 24, 2026 | Stefan Lutz | Sale | 5,862 | $1.13 |
| Feb 24, 2026 | Stefan Lutz | Sale | 5,862 | $1.13 |
| Feb 24, 2026 | Stefan Lutz | Sale | 5,862 | $1.13 |
| Feb 6, 2026 | Alison Moore | Sale | 3,826 | $1.31 |
| Feb 6, 2026 | Alison Moore | Sale | 3,826 | $1.31 |
| Feb 6, 2026 | Alison Moore | Sale | 3,826 | $1.31 |
| Feb 6, 2026 | Alison Moore | Sale | 3,826 | $1.31 |
| Feb 6, 2026 | Stefan Lutz | Sale | 2,492 | $1.31 |
| Feb 6, 2026 | Stefan Lutz | Sale | 2,492 | $1.31 |
| Feb 6, 2026 | Stefan Lutz | Sale | 2,492 | $1.31 |
CDXS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $70.39M | $-43.97M | -0.50 | $-19.38M |
| Dec 31, 2024 | $59.34M | $-65.28M | -0.89 | $-49.41M |
| Dec 31, 2023 | $70.14M | $-76.24M | -1.12 | $-52.64M |
| Dec 31, 2022 | $138.59M | $-33.59M | -0.51 | $11.28M |
| Dec 31, 2021 | $104.75M | $-21.28M | -0.33 | $-14.27M |
Latest balance sheet: total assets $120.06M, total liabilities $87.10M, cash $27.17M (as of Jun 30, 2026).
CDXS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $1.48 |
| Jul 23, 2026 | 8-K Item 2.02 (results) | $1.99 |
| May 7, 2026 | 8-K Item 2.02 (results) | $2.58 |
| Mar 11, 2026 | 8-K Item 2.02 (results) | $1.27 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $2.04 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $3.05 |
| May 14, 2025 | 8-K Item 2.02 (results) | $2.47 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $3.93 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $3.14 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 28, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Industrial Organic Chemicals
LyondellBasell Industries (LYB)International Flavors & Fragrances (IFF)Newmarket (NEU)Westlake (WLK)Sensient Technologies (SXT)Methanex (MEOH)Green Plains (GPRE)Rex American Resources (REX)Gevo (GEVO)Alto Ingredients (ALTO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CDXS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.